ExploreWatchlistsPricing
  1. JP-listed companies
  2. noevir holdings co.,ltd.
  3. Financials
  4. Capital expenditures

noevir holdings co.,ltd. (4928)

Market cap
¥147.7B
P/E ratio
18x
Noevir Holdings manufactures and sells cosmetics, pharmaceuticals, and food products through face-to-face sales agents and retail channels in Japan and overseas markets.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Sep 30, 2025-2,266+261.98%
Sep 30, 2024-626-14.95%
Sep 30, 2023-736+34.80%
Sep 30, 2022-546+45.21%
Sep 30, 2021-376-77.00%
Sep 30, 2020-1,635-10.75%
Sep 30, 2019-1,832+45.28%
Sep 30, 2018-1,261-16.88%
Sep 30, 2017-1,517-10.24%
Sep 30, 2016-1,690-28.15%
Sep 30, 2015-2,352-19.97%
Sep 30, 2014-2,939

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat